These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9744538)

  • 21. The effect of the dose of diethylnitrosamine on the initiation of altered hepatic foci in neonatal female rats.
    Dragan YP; Xu YH; Pitot HC
    Carcinogenesis; 1993 Mar; 14(3):385-91. PubMed ID: 8095861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovariectomy promotes the growth of altered hepatic foci after withdrawal and reintroduction of phenobarbital during hepatocarcinogenesis in rats.
    Hendrich S; Leveston AO; Pitot HC
    Eur J Cancer Prev; 1992 Oct; 1(6):407-14. PubMed ID: 1361160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
    Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA
    Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver.
    Lee KW; Wang HJ; Murphy PA; Hendrich S
    Nutr Cancer; 1995; 24(3):267-78. PubMed ID: 8610046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the rat.
    Hendrich S; Glauert HP; Pitot HC
    Nutr Cancer; 1989; 12(3):249-58. PubMed ID: 2771802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis.
    Pitot HC; Goodspeed D; Dunn T; Hendrich S; Maronpot RR; Moran S
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):23-34. PubMed ID: 2563599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a high-sucrose diet on the development of enzyme-altered foci in chemical hepatocarcinogenesis in rats.
    Hei TK; Sudilovsky O
    Cancer Res; 1985 Jun; 45(6):2700-5. PubMed ID: 2859110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phenotypic stability of altered hepatic foci: effect of the short-term withdrawal of phenobarbital and of the long-term feeding of purified diets after the withdrawal of phenobarbital.
    Glauert HP; Schwarz M; Pitot HC
    Carcinogenesis; 1986 Jan; 7(1):117-21. PubMed ID: 2867834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat.
    Pitot HC; Campbell HA; Maronpot R; Bawa N; Rizvi TA; Xu YH; Sargent L; Dragan Y; Pyron M
    Toxicol Pathol; 1989; 17(4 Pt 1):594-611; discussion 611-2. PubMed ID: 2697939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis.
    Garcea R; Daino L; Pascale R; Simile MM; Puddu M; Frassetto S; Cozzolino P; Seddaiu MA; Gaspa L; Feo F
    Cancer Res; 1989 Apr; 49(7):1850-6. PubMed ID: 2564313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
    Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC
    Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver.
    Laconi E; Tessitore L; Milia G; Yusuf A; Sarma DS; Todde P; Pani P
    Carcinogenesis; 1995 Aug; 16(8):1865-9. PubMed ID: 7634416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency.
    Flodström S; Busk L; Kronevi T; Ahlborg UG
    Fundam Appl Toxicol; 1991 Feb; 16(2):375-91. PubMed ID: 2055368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative comparison of initiation and mutation phenotypes in hepatocytes of the analbuminemic rat.
    Dragan YP; Laufer C; Koleske AJ; Drinkwater N; Pitot HC
    Jpn J Cancer Res; 1993 Feb; 84(2):175-83. PubMed ID: 8463134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S; Merlino GT; Ward JM
    Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
    Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
    Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
    Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.